[1] LIU T T, LING C B, TIAN J, et al.Protective effect of shikonin in myocardial ischemia/reperfusion injury in rats by inhibition of autophagy through the Hippo pathway[J]. Biochem Biophys Res Commun,2022,613:87-93. [2] BU W Y, ZHANG Z Y, OCANSEY D K W, et al. Research on natural products from traditional Chinese medicine in the treatment of myocardial ischemia-reperfusion injury[J]. Am J Transl Res,2022,14:1952-1968. [3] LI L, LIN L, LEI S Q, et al.Maslinic Acid Inhibits Myocardial Ischemia-Reperfusion Injury-Induced Apoptosis and Necroptosis via Promoting Autophagic Flux[J]. DNA Cell Biol,2022,41:487-497. [4] 杜婷婷,张志明.基于中医气血津液理论探讨细胞自噬与心肌缺血再灌注损伤的相关性[J].中华中医药杂志,2021,36(12):7086-7088. [5] CHANG C M, JENSEN L E, HURLEY J H.Autophagosome biogenesis comes out of the black box[J]. Nat Cell Biol,2021,23(5):450-456. [6] DONG Y, UNDYALA V V, GOTTLIEB R A, et al.Autophagy: definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury[J]. J Cardiovasc Pharmacol Ther,2010,15(3):220-230. [7] ZENG C, Li H, FAN Z W, et al.Crocin-Elicited Autophagy Rescues Myocardial Ischemia/Reperfusion Injury via Paradoxical Mechanisms[J]. Am J Chin Med,2016,44:515-530. [8] 邱敏,孙科,陶劲,等.《金匮要略》胸痹“阳微阴弦”病机探微[J].中国中医基础医学杂志,2017,23(2):151-152. [9] 桂诗琪,于峥,屈伸,等.《仁斋直指方论》学术思想研究[J].中国中医基础医学杂志,2016,22(6):744-747. [10] 邵笑,邓悦. 气血津液理论在心血管疾病中的应用研究进展[J].中西医结合心脑血管病杂志,2020,18(17):2801-2803. [11] 林飞,陈恒文,石卓林,等.基于microRNA和mtDNA的相关性阐述活血化痰中药防御心肌缺血再灌注损伤的分子机制[J].中国中药杂志,2017,42(5):1005-1010. [12] 胡婷,包怡敏. 益气活血法抗心肌缺血再灌注损伤的作用机制[J].中国实验方剂学杂志,2018,24(22):228-234. [13] 何贵新,肖婷,秦伟彬,等.基于PI3K/AKT信号通路探讨芪参益气滴丸改善心肌缺血再灌注损伤的实验研究[J].北京中医药大学学报,2020,43(9):762-768. [14] 闫清支,郝蔷薇,麻春杰.自噬在心肌缺血再灌注损伤中的作用及中医药干预研究概况[J].中国老年学杂志,2017,37(12):3083-3086. [15] 谢延峥,马金,姚耿圳,等. 细胞程序性死亡与心肌缺血再灌注损伤的关系及中医药干预新视角[J].中国中药杂志,2021,46(6):1345-1356. [16] 李檫,李益萍,王肖龙. 基于mTOR通路探讨中医药调控心肌缺血/再灌注损伤中自噬的研究进展[J].中华中医药杂志,2021,36(12):7242-7247. [17] 谢连娣,刘洋,周琨,等.心肌缺血再灌注损伤的中医病机浅识[J].中华中医药杂志,2015,30(9):3139-3141. [18] 罗晨曦. 益气活血方对冠心病气虚血瘀证大鼠心肌线粒体自噬的作用机制研究[D].北京:北京中医药大学,2018. [19] 李圣耀,徐浩,史大卓.刍议冠心病的气血津液辨治[J].中医杂志,2017,58(4):300-302. [20] 冯冠,郭凯波,严卿莹,等.从中医气血津液论述自噬治疗恶性肿瘤的理论依据[J].新中医,2019,51(6):326-328. [21] QIN G W, LU P, PENG L, et al.Ginsenoside Rb1 Inhibits Cardiomyocyte Autophagy via PI3K/Akt/mTOR Signaling Pathway and Reduces Myocardial Ischemia/Reperfusion Injury[J]. Am J Chin Med,2021,49:1913-1927. [22] HUANG K Y, YU Y W, LIU S, et al.A Single, Acute Astragaloside IV Therapy Protects Cardiomyocyte Through Attenuating Superoxide Anion-Mediated Accumulation of Autophagosomes in Myocardial Ischemia-Reperfusion Injury[J]. Front Pharmacol,2021,12:642925. [23] 孙大伟,索艳荣,冯丽莎,等.基于自噬基因Beclin-1与LC3探讨丹参素对心肌缺血再灌注损伤大鼠心肌ATP5G1的影响[J].中华中医药杂志,2019,34(6):2421-2425. [24] SHI X, ZHU H, ZHANG Y, et al.XuefuZhuyu decoction protected cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy[J]. BMC Complement Altern Med,2017,17(1): 325. [25] 唐丹丽,刘寨华,崔海峰,等.栝楼薤白半夏汤对心肌缺血再灌注损伤大鼠心肌自噬及凋亡的影响[J].中国中医基础医学杂志,2016,22(2):177-180. [26] 杨海龙,刘春萍,刘建滔,等.基于自噬探讨丹蒌片减轻心肌缺血再灌注损伤的机制研究[J].中国中西医结合杂志,2020,40(3):318-323. [27] 黄贵华,纪云西,吴大力,等.细胞自噬与中医气虚痰瘀关系探讨[J].中医杂志,2011,52(20):1717-1719. |